NFKB1 and gastric cancer: Numerous studies have revealed that constitutively activated NF-ĸB signalling plays vital roles in the development and progression of gastric cancer, and blockade of the NF-κB pathway inhibits gastric cancer cell proliferation, sensitises cells to chemotherapeutic drugs, and even suppresses distant metastasis [4–7].